Barclays Starts DexCom (DXCM) at Overweight
Barclays analyst Matt Miksic initiates coverage on DexCom (NASDAQ: DXCM) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

